Rabies

Indications: The vaccine provides immunity against rabies. It contains an inactivated form of the virus, which causes the rabies.

Vaccination: Three injections are needed (on day 0, 7, and 28.)

Protection: Vaccination gives protection for about five years then revaccination is needed for further protection.

Side effects include:

• cold or flue-like symptoms
• Fever
• Malaise

Rabies Vaccination Resource:

Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau.
Agergaard J, Nante E, Poulstrup G, Nielsen J, Flanagan KL, Østergaard L, Benn CS, Aaby P.
Vaccine. 2011 Jan 10;29(3):487-500. Epub 2010 Nov 18
Immunization coverage and its determinants among children 12-23 months of age in Aden, Yemen.
Basaleem HO, Al-Sakkaf KA, Shamsuddin K.
Saudi Med J. 2010 Nov;31(11):1221-6
Bullous pemphigoid in infancy developing after the first vaccination.
Hafiji J, Bhogal B, Rytina E, Burrows NP.
Clin Exp Dermatol. 2010 Dec;35(8):940-1. doi: 10.1111/j.1365-2230.2010.03839.x. No abstract available.
Outbreaks following wild poliovirus importations --- Europe, Africa, and Asia, January 2009-September 2010.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2010 Nov 5;59(43):1393-9
Mass immunisation campaign against polio in Africa reports "high coverage".
Zarocostas J.
BMJ. 2010 Nov 3;341:c6222. doi: 10.1136/bmj.c6222. No abstract available.
Poliovirus vaccine and vaccine-derived polioviruses.
Plotkin SA.
N Engl J Med. 2010 Nov 4;363(19):1870; author reply 1870-1. No abstract available.
Poliovirus vaccine and vaccine-derived polioviruses.
Shulman LM, Manor Y, Sofer D.
N Engl J Med. 2010 Nov 4;363(19):1870; author reply 1870-1. No abstract available.
Primary immune deficiency disease awareness among a group of Turkish physicians.
Yüksek M, Ikincioğullari A, Doğu F, Elhan A, Yüksek N, Reisli I, Babacan E.
Turk J Pediatr. 2010 Jul-Aug;52(4):372-7
Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj).
[No authors listed]
Wkly Epidemiol Rec. 2010 Oct 22;85(43):425-8. English, French. No abstract available.
Global routine vaccination coverage, 2009.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1367-71
A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design.
D'Argenio DA, Wilson CB.
Immunity. 2010 Oct 29;33(4):437-40
Economic analysis of the global polio eradication initiative.
Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Wassilak SG, Linkins J, Sutter RW, Aylward RB, Thompson KM.
Vaccine. 2010 Dec 16;29(2):334-43. Epub 2010 Oct 26
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.
Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, Deshpande J, Singh AP, Sreevatsava M, Malankar P, Burton A, Chatterjee A, Jafari H, Aylward RB.
Lancet. 2010 Nov 13;376(9753):1682-8. Epub 2010 Oct 25
Poliomyelitis eradication: another step forward.
Crawford NW, Buttery JP.
Lancet. 2010 Nov 13;376(9753):1624-5. Epub 2010 Oct 25. No abstract available.
[Problems of prevention and control of poliomyelitis in Poland].
Mazurowska-Magdzik W, Bucholc B, Janaszek-Seydlitz W, Szkoda T, Magdzik W.
Przegl Epidemiol. 2010;64(3):341-7. Polish.
Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases.
Staat MA, Stadler LP, Donauer S, Trehan I, Rice M, Salisbury S.
Vaccine. 2010 Nov 23;28(50):7947-55. Epub 2010 Oct 29
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR, Romanò L, Giambi C, Pavan A, Carnelli V, Baitelli G, Malchiodi G, Valerio E, Barale A, Marchisio MA, Montù D, Tozzi AE, D'Ancona F; study group.
Lancet Infect Dis. 2010 Nov;10(11):755-61. Epub 2010 Sep 29
Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant.
Asahina N, Matsunami Y, Sueda K, Shiraishi H, Saitoh S.
Pediatr Int. 2010 Oct;52(5):838-41. doi: 10.1111/j.1442-200X.2010.03132.x. No abstract available.
Health conditions for travelers to Saudi Arabia for (Hajj) for the year 1431H/2010.
Memish ZA.
J Infect Public Health. 2010;3(3):92-4. No abstract available.
Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S, Guiso N, Baptiste C, Desaint C, Desforges L, Lebon P, Soubeyrand B, Launay O.
Hum Vaccin. 2010 Oct;6(10):829-34. Epub 2010 Oct 1
First Prev 5 6 7 8 9 10 11 12 13 Next Last 201/4009 Jump: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201

To top Back to list of vaccination • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster